Hedgehog Signaling Pathway and Autophagy in Cancer

Area of Science:

• Oncology
• Molecular Biology
• Cellular Biology

Background:

• The Hedgehog (Hh) signaling pathway regulates vertebrate development but its aberrant activation drives tumorigenesis and cancer progression.
• While Hh inhibitors show success in basal cell carcinoma, their efficacy is limited in other cancers like lung, leukemia, and pancreatic cancer.
• Autophagy, a cellular degradation process, is implicated in cancer initiation, progression, and drug resistance.

Purpose of the Study:

• To review recent advances in understanding the Hedgehog (Hh) pathway and autophagy in cancer.
• To explore the crosstalk between Hh signaling and autophagy in various cancer types.
• To highlight the therapeutic opportunities arising from modulating this crosstalk.

Main Methods:

• Literature review of recent scientific publications.
• Analysis of studies investigating Hh pathway and autophagy in cancer.
• Examination of preclinical and clinical data on targeting Hh-autophagy interactions.

Main Results:

• Hedgehog (Hh) signaling and autophagy exhibit significant crosstalk in multiple cancers.
• Modulating this Hh-autophagy interaction can sensitize both primary and drug-resistant cancer cells to Hh inhibitors.
• This crosstalk presents a novel strategy to enhance Hh inhibitor efficacy in resistant tumors.

Conclusions:

• The interplay between Hh signaling and autophagy is a critical factor in cancer biology.
• Targeting the Hh-autophagy axis offers a promising approach to overcome therapeutic resistance in various cancers.
• Further research into this crosstalk could lead to the development of more effective cancer therapies.